Skip to main content
    E

    Embecta Corp (EMBC)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $6.25
    -0.21 (-3.25%)

    Market Cap: $366.02M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Embecta Corp (EMBC) Financials: Revenue, Profit and Cash Flow

    Updated Aug 7, 2026. Financial statements from company filings, amounts in US dollars.

    Embecta reported revenue of $1.08B for the fiscal year ended Sep 30, 2025, down 3.8% from the year before. That year, net income was $95.40M with a net margin of 8.8%, operating cash flow was $191.70M and free cash flow was $182.40M. The quarter ended Jun 30, 2026 had revenue of $271.70M and net income of $21.10M.

    Revenue and Margins

    The operating margin was 22.4% in the fiscal year ended Sep 2025. Over the 6 years to Sep 2025, revenue fell from $1.11B, a compound annual decline of 0.5%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Sep 2025$1.08B-3.8%62.6%22.4%8.8%
    Sep 2024$1.12B+0.2%65.5%14.9%7.0%
    Sep 2023$1.12B-0.8%66.9%19.8%6.3%
    Sep 2022$1.13B-3.1%68.6%27.4%19.8%
    Sep 2021$1.17B+7.4%68.7%42.2%35.6%
    Sep 2020$1.09B-2.1%70.3%44.8%39.4%
    Sep 2019$1.11BN/A70.9%45.3%39.0%
    Annual, fiscal years ended Sep 2019 to Sep 2025

    Income Statement

    In the fiscal year ended Sep 2025, net income rose 21.8% from the year before. In the quarter ended Jun 2026, net income fell 53.6% from the same quarter a year earlier.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019
    Revenue$1.08B$1.12B$1.12B$1.13B$1.17B$1.09B$1.11B
    Cost of revenue$403.60M$387.90M$370.90M$354.60M$364.90M$322.90M$323.00M
    Gross profit$676.80M$735.20M$749.90M$774.90M$800.40M$762.60M$786.00M
    Research and development$37.30M$78.80M$85.20M$66.90M$63.30M$61.40M$62.00M
    Operating income$242.10M$166.80M$221.50M$309.60M$492.00M$486.50M$502.00M
    Net income$95.40M$78.30M$70.40M$223.60M$414.80M$427.60M$432.00M
    EBITDA$303.80M$205.90M$251.70M$337.70M$533.20M$524.80M$536.00M
    Fiscal years ended Sep 2019 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$271.70M$221.80M$261.20M$264.00M$295.50M$259.00M$261.90M$286.10M$272.50M$287.20M$277.30M$281.90M
    Gross profit$153.30M$127.80M$161.70M$158.50M$197.10M$164.10M$157.10M$173.80M$190.10M$185.40M$185.90M$181.80M
    Operating income$48.70M$35.00M$83.30M$56.50M$94.00M$62.90M$28.70M$26.20M$55.90M$39.20M$45.50M$25.80M
    Net income$21.10M-$4.10M$44.10M$26.40M$45.50M$23.50M$0$14.60M$14.70M$28.90M$20.10M$6.00M
    Last 12 quarters

    Balance Sheet

    As of Sep 2025, total debt of $1.40B exceeded cash and equivalents by $1.17B. Shareholder equity was negative, at -$650.60M, as total liabilities of $1.74B exceeded total assets of $1.09B.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019
    Total assets$1.09B$1.29B$1.21B$1.09B$788.00M$738.00M$745.00M
    Current assets$631.40M$761.00M$749.10M$664.70M$291.80M$235.00M$248.00M
    Cash and equivalents$225.50M$267.50M$326.30M$330.90M$0N/AN/A
    Total liabilities$1.74B$2.02B$2.04B$1.98B$193.70M$166.00M$126.00M
    Short-term debt$9.50M$9.50M$9.50M$9.50M$0$1.00MN/A
    Long-term debt$1.39B$1.57B$1.59B$1.60B$0N/AN/A
    Shareholder equity-$650.60M-$738.30M-$821.70M-$891.40M$594.30M$572.00M$577.00M
    Fiscal years ended Sep 2019 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$1.27B$1.03B$1.06B$1.09B$1.16B$1.12B$1.15B$1.29B$1.27B$1.20B$1.22B$1.21B
    Total liabilities$1.88B$1.66B$1.68B$1.74B$1.83B$1.86B$1.92B$2.02B$2.03B$1.97B$2.01B$2.04B
    Cash and equivalents$214.70M$184.90M$201.30M$225.50M$230.60M$209.30M$210.00M$267.50M$275.10M$299.80M$298.70M$326.30M
    Shareholder equity-$612.70M-$626.10M-$613.10M-$651.20M-$669.60M-$736.20M-$768.80M-$738.30M-$763.70M-$769.60M-$793.50M-$821.70M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Sep 2025, free cash flow was 95.1% of operating cash flow. Dividends came to 19.2% of it.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019
    Operating cash flow$191.70M$35.70M$67.70M$412.20M$456.30M$498.50M$505.00M
    Capital expenditures$9.30M$15.80M$26.50M$23.60M$36.80M$41.90M$69.00M
    Free cash flow$182.40M$19.90M$41.20M$388.60M$419.50M$456.60M$436.00M
    Dividends paid$35.00M$34.50M$34.40M$8.60M$0$0$8.60M
    Investing cash flow-$9.30M-$15.80M-$26.50M-$24.00M-$39.20M-$41.90M-$69.00M
    Financing cash flow-$226.70M-$73.40M-$48.70M-$48.00M-$417.10M-$456.60M-$436.00M
    Fiscal years ended Sep 2019 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow$41.80M$31.10M$17.20M$84.00M$81.20M$31.80M-$5.30M$26.60M-$2.10M$24.30M-$13.10M$29.60M
    Capital expenditures$1.10M$500.00K$600.00K$7.30M$400.00K$100.00K$1.50M$0$9.70M$3.40M$2.70M$9.20M
    Free cash flow$40.70M$30.60M$16.60M$76.70M$80.80M$31.70M-$6.80M$26.60M-$11.80M$20.90M-$15.80M$20.40M
    Last 12 quarters

    Frequently Asked Questions About EMBC

    What is Embecta's annual revenue?

    Embecta reported revenue of $1.08B for the fiscal year ended Sep 30, 2025.

    How fast is Embecta's revenue growing?

    Revenue was down 3.8% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -1.5%.

    Is Embecta profitable?

    Yes. Embecta reported net income of $95.40M for the fiscal year ended Sep 30, 2025, with a net margin of 8.8%.

    How much free cash flow does EMBC generate?

    For the fiscal year ended Sep 30, 2025, operating cash flow of $191.70M minus capital expenditures of $9.30M produced free cash flow of $182.40M.

    How much debt does Embecta have?

    The balance sheet dated Sep 30, 2025 reported long-term debt of $1.39B, short-term debt of $9.50M and cash and equivalents of $225.50M.